Literature DB >> 12825729

The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode.

P Cumberland1, D Sethi, P J Roderick, J G Wheeler, J M Cowden, J A Roberts, L C Rodrigues, M J Hudson, D S Tompkins.   

Abstract

The sequelae of Infectious Intestinal Disease (IID) in a population-based sample of cases and matched controls were investigated for a period of 3 months following the initial infection. Incident cases of IID presenting to GPs or occurring in the community and controls were studied at 3 weeks and over a 3-month follow-up period. Cases were six times more likely than controls to have gastrointestinal symptoms, particularly diarrhoea, at 3 weeks. Ten per cent of cases consulted their GP in the 3 months after episode and 2.3% were referred to hospital. GP presentation rates were twice as high in cases. Gastrointestinal symptoms persist after IID, leading to an increased likelihood of GP consultation and hospital referral. Diagnosis of irritable bowel syndrome may be more likely following IID. The burden of IID is likely to be considerable given its high incidence and the frequency of such sequelae.

Entities:  

Mesh:

Year:  2003        PMID: 12825729      PMCID: PMC2869981          DOI: 10.1017/s0950268803008410

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Immune activation and gut microbes in irritable bowel syndrome.

Authors:  Khaldun Al-Khatib; Henry C Lin
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

Review 3.  Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.

Authors:  Fabiane Klem; Akhilesh Wadhwa; Larry J Prokop; Wendy J Sundt; Gianrico Farrugia; Michael Camilleri; Siddharth Singh; Madhusudan Grover
Journal:  Gastroenterology       Date:  2017-01-06       Impact factor: 22.682

4.  Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands.

Authors:  I H M Friesema; R F de Boer; E Duizer; L M Kortbeek; D W Notermans; O F Norbruis; D D L Bezemer; H van Heerbeek; R N J van Andel; J G van Enk; P L A Fraaij; M P G Koopmans; A M D Kooistra-Smid; Y T H P van Duynhoven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-03       Impact factor: 3.267

5.  First do no harm: giving the patient the single positive diagnosis that offers them the best outcome.

Authors:  Wilfrid Treasure
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

6.  Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial.

Authors:  Kristin A Zernicke; Tavis S Campbell; Philip K Blustein; Tak S Fung; Jillian A Johnson; Simon L Bacon; Linda E Carlson
Journal:  Int J Behav Med       Date:  2013-09

7.  Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle East.

Authors:  Mark S Riddle; David R Tribble; Shannon D Putnam; Manal Mostafa; Theodore R Brown; Andrew Letizia; Adam W Armstrong; John W Sanders
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

Review 8.  Role of gut pathogens in development of irritable bowel syndrome.

Authors:  Madhusudan Grover
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

9.  Association between vasomotor rhinitis and irritable bowel syndrome.

Authors:  Maria Lauriello; Alberto Eibenstein; Anna Maria Angelone; Marina Pasqua; Cinzia Tucci; Carla Di Giacomo; Arnaldo Salerno; Giuseppe Frieri; Marco Fusetti
Journal:  Allergy Rhinol (Providence)       Date:  2016-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.